BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7262161)

  • 61. PHASE I clinical trial of an oral solution of VP-16-213.
    Nissen NI; Dombernowsky P; Hansen HH; Larsen V
    Cancer Treat Rep; 1976 Jul; 60(7):943-5. PubMed ID: 1009527
    [No Abstract]   [Full Text] [Related]  

  • 62. [VM-26 salvage therapy for refractory or recurrent germinal testicular cancers].
    Miki T; Oda H; Saiki S; Kinouchi T; Kuroda M; Kiyohara H; Usami M; Kotake T
    Hinyokika Kiyo; 1985 Sep; 31(9):1649-56. PubMed ID: 4083220
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
    Kanda T; Oka M; Hara K; Koteda T; Ishizaki T; Ikebe A; Nakano M; Iwasaki H; Tsutsumi T; Okuno K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):12-8. PubMed ID: 3009666
    [No Abstract]   [Full Text] [Related]  

  • 64. Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.
    Ponder BA; Oliver RT
    Cancer Chemother Pharmacol; 1984; 12(1):64-5. PubMed ID: 6690078
    [TBL] [Abstract][Full Text] [Related]  

  • 65. VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung.
    Eagan RT; Ingle JN; Creagan ET; Frytak S; Kvols LK; Rubin J; McMachon RT
    Cancer Treat Rep; 1978 May; 62(5):843-4. PubMed ID: 657168
    [No Abstract]   [Full Text] [Related]  

  • 66. [Etoposide: VP-16].
    Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1982; 119(2):15-8. PubMed ID: 7160031
    [No Abstract]   [Full Text] [Related]  

  • 67. Vinblastine in the management of testicular cancer.
    Samuels ML; Howe CD
    Cancer; 1970 May; 25(5):1009-17. PubMed ID: 5443728
    [No Abstract]   [Full Text] [Related]  

  • 68. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
    Kimura K; Yamada K; Yoshida T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of VP-16-213 in malignant lymphoma and melanoma.
    Cecil JW; Quagliana JM; Coltman CA; Al-Sarraf M; Thigpen T; Groppe CW
    Cancer Treat Rep; 1978 May; 62(5):801-3. PubMed ID: 657164
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Randomized phase II study with VP-16-213 (etoposide) in the treatment of advanced breast cancer].
    Cavalli F; Jungi WF; Brunner KW
    Onkologie; 1981 Apr; 4(2):80-3. PubMed ID: 7022286
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Salvage chemotherapy of far advanced testicular cancer with VP-16 and CDDP].
    Gotoh S; Fukui I; Kasamatsu T; Nagahama K; Kitahara S; Kihara K; Takeuchi S; Higashi Y; Ohshima H; Nagamatsu H
    Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):732-7. PubMed ID: 3226023
    [No Abstract]   [Full Text] [Related]  

  • 72. Phase II study of etoposide for carcinoma of the prostate.
    Walther PJ; Williams SD; Troner M; Greco FA; Birch R; Einhorn LH
    Cancer Treat Rep; 1986 Jun; 70(6):771-2. PubMed ID: 3524825
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors.
    Higby DJ; Wallace HJ; Albert DJ; Holland JF
    Cancer; 1974 May; 33(5):1219-5. PubMed ID: 4856724
    [No Abstract]   [Full Text] [Related]  

  • 74. [Effects of oral etoposide in small cell carcinoma of the lung].
    Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral etoposide in gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Cancer Treat Rep; 1984 May; 68(5):775-7. PubMed ID: 6327035
    [TBL] [Abstract][Full Text] [Related]  

  • 76. VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.
    Tempero M; Kessinger A; Lemon HM
    Cancer Clin Trials; 1981; 4(2):155-7. PubMed ID: 6265110
    [No Abstract]   [Full Text] [Related]  

  • 77. [Phase II study of etoposide in malignant lymphoma].
    Onoshi T; Hayashi K; Ueoka H; Nishihara R; Toyota K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):952-3. PubMed ID: 6721509
    [No Abstract]   [Full Text] [Related]  

  • 78. VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.
    Cavalli F; Sonntag RW; Jungi F; Senn HJ; Brunner KW
    Cancer Treat Rep; 1978 Mar; 62(3):473-5. PubMed ID: 348319
    [No Abstract]   [Full Text] [Related]  

  • 79. [cis-Diamino-dichloro-platinum (II) in the treatment of otherwise treatment-resistant malignant testicular teratoma (author's transl)].
    Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1976 Feb; 101(6):191-5, 199. PubMed ID: 1248396
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chemotherapy of refractory germ cell cancer with Etoposide.
    Lederman GS; Garnick MB; Canellos GP; Richie JP
    J Clin Oncol; 1983 Nov; 1(11):706-9. PubMed ID: 6321675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.